UBOT vs. CURE

Last updated Jun 13, 2026

UBOT (Direxion Robotics, Artificial Intelligence & Automation Index Bull 3X Shares) and CURE (Direxion Daily Healthcare Bull 3x Shares) are both exchange-traded funds - UBOT is a Robotics fund tracking the Indxx Global Robotics & Artificial Intelligence Thematic Index (300%), while CURE is a Leveraged Equities fund tracking the Health Care Select Sector Index (300%). Both are passively managed. Over the past 5 years, UBOT returned -9.40%/yr vs 1.51%/yr for CURE. At a 0.48 correlation, their price movements are largely independent. UBOT charges 1.29%/yr vs 1.08%/yr for CURE.

Performance

UBOT vs. CURE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Robotics, Artificial Intelligence & Automation Index Bull 3X Shares (UBOT) and Direxion Daily Healthcare Bull 3x Shares (CURE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, UBOT achieves a -1.41% return, which is significantly higher than CURE's -7.96% return.

UBOT

• 1D: -0.59%
• 1M: -21.50%
• YTD: -1.41%
• 6M: -1.92%
• 1Y: 24.92%
• 3Y*: 3.57%
• 5Y*: -9.40%
• 10Y*: —

CURE

• 1D: -0.55%
• 1M: 13.53%
• YTD: -7.96%
• 6M: -6.00%
• 1Y: 26.46%
• 3Y*: 3.05%
• 5Y*: 1.51%
• 10Y*: 13.49%

*Multi-year figures are annualized to reflect compound growth (CAGR)

UBOT vs. CURE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
UBOT Direxion Robotics, Artificial Intelligence & Automation Index Bull 3X Shares	-1.41%	13.42%	12.02%	72.59%	-72.45%	9.78%	80.13%	87.34%	-71.74%
CURE Direxion Daily Healthcare Bull 3x Shares	-7.96%	22.55%	-8.47%	-9.40%	-20.51%	88.30%	5.02%	55.66%	5.00%

Correlation

The correlation between UBOT and CURE is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.24
Correlation (3Y) Calculated over the trailing 3-year period	0.31
Correlation (5Y) Calculated over the trailing 5-year period	0.41
Correlation (All Time) Calculated using the full available price history since Apr 19, 2018	0.48

Over the past year, the correlation between UBOT and CURE has dropped to 0.24 - well below their long-term average of 0.48, suggesting their price drivers have been diverging.

UBOT vs. CURE - Sectors Allocation Comparison

Sectors	UBOT	CURE
Industrials	48.6%	-
Technology	31.8%	-
Healthcare	9.0%	100.0%
Consumer Cyclical	6.1%	-
Communication Services	4.5%	-
Financial Services	0.9%	-
Energy	0.5%	-
Consumer Defensive	0.0%	-
Basic Materials	0.0%	-
Utilities	0.0%	-
Real Estate	-	-

Return for Risk

UBOT vs. CURE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UBOT

UBOT Risk / Return Rank: 20
UBOT Sharpe Ratio Rank: 18
UBOT Sortino Ratio Rank: 21
UBOT Omega Ratio Rank: 20
UBOT Calmar Ratio Rank: 19
UBOT Martin Ratio Rank: 21

CURE

CURE Risk / Return Rank: 21
CURE Sharpe Ratio Rank: 20
CURE Sortino Ratio Rank: 24
CURE Omega Ratio Rank: 22
CURE Calmar Ratio Rank: 22
CURE Martin Ratio Rank: 19

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UBOT vs. CURE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Robotics, Artificial Intelligence & Automation Index Bull 3X Shares (UBOT) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	UBOT	CURE	Difference
Sharpe ratio: Return per unit of total volatility	0.50	0.60	-0.10
Sortino ratio: Return per unit of downside risk	1.03	1.18	-0.15
Omega ratio: Gain probability vs. loss probability	1.12	1.13	-0.01
Calmar ratio: Return relative to maximum drawdown	0.70	0.85	-0.16
Martin ratio: Return relative to average drawdown	2.14	1.94	+0.20

UBOT vs. CURE - Sharpe Ratio Comparison

The current UBOT Sharpe Ratio is 0.50, which is comparable to the CURE Sharpe Ratio of 0.60. The chart below compares the historical Sharpe Ratios of UBOT and CURE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

UBOT vs. CURE - Drawdown Comparison

The maximum UBOT drawdown since its inception was -86.24%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for UBOT and CURE.

Drawdown Indicators

	UBOT	CURE	Difference
Max Drawdown Largest peak-to-trough decline	-86.24%	-69.19%	-17.05%
Max Drawdown (1Y) Largest decline over 1 year	-35.90%	-31.10%	-4.80%
Max Drawdown (3Y) Largest decline over 3 years	-51.64%	-51.93%	+0.29%
Max Drawdown (5Y) Largest decline over 5 years	-82.90%	-52.23%	-30.67%
Max Drawdown (10Y) Largest decline over 10 years	—	-69.19%	—
Current Drawdown Current decline from peak	-52.26%	-26.94%	-25.32%
Average Drawdown Average peak-to-trough decline	-49.81%	-18.16%	-31.65%
Ulcer Index Depth and duration of drawdowns from previous peaks	11.67%	13.71%	-2.04%

Volatility

UBOT vs. CURE - Volatility Comparison

Direxion Robotics, Artificial Intelligence & Automation Index Bull 3X Shares (UBOT) has a higher volatility of 17.69% compared to Direxion Daily Healthcare Bull 3x Shares (CURE) at 14.30%. This indicates that UBOT's price experiences larger fluctuations and is considered to be riskier than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	UBOT	CURE	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.69%	14.30%	+3.39%
Volatility (6M) Calculated over the trailing 6-month period	38.70%	30.87%	+7.83%
Volatility (1Y) Calculated over the trailing 1-year period	49.90%	44.32%	+5.58%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	53.27%	43.84%	+9.43%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	63.55%	49.59%	+13.96%

UBOT vs. CURE - Expense Ratio Comparison

UBOT has a 1.29% expense ratio, which is higher than CURE's 1.08% expense ratio.

Dividends

UBOT vs. CURE - Dividend Comparison

UBOT's dividend yield for the trailing twelve months is around 0.94%, less than CURE's 1.16% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
CURE Direxion Daily Healthcare Bull 3x Shares	1.16%	1.12%	1.17%	2.02%	0.38%	0.02%	0.17%	0.40%	0.70%	0.18%
UBOT Direxion Robotics, Artificial Intelligence & Automation Index Bull 3X Shares	0.94%	0.78%	1.45%	0.65%	0.00%	2.25%	15.83%	0.55%	0.33%	0.00%

Frequently Asked Questions

Can I hold both UBOT and CURE in my portfolio?

UBOT and CURE have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, UBOT or CURE?

UBOT has higher volatility (17.69%) compared to CURE (14.30%). In terms of maximum drawdown, UBOT dropped -86.24% vs CURE's -69.19%.

Which ETF is better, UBOT or CURE?

On 5-year performance, CURE leads with 1.51% vs -9.40% for UBOT. On fees, CURE is cheaper at 1.08% per year. On volatility, CURE has been the lower-risk option at 14.30%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, UBOT or CURE?

Over the 5-year period, CURE has performed better with a 1.51% return vs -9.40%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, UBOT or CURE?

CURE is cheaper with a 1.08% expense ratio, compared with 1.29% for UBOT.

Which ETF pays a higher dividend yield, UBOT or CURE?

CURE has the higher dividend yield at 1.16%, compared with 0.94% for UBOT.

What is the main difference between UBOT and CURE?

UBOT is categorized as Robotics, while CURE is Leveraged Equities. UBOT tracks Indxx Global Robotics & Artificial Intelligence Thematic Index (300%), while CURE tracks Health Care Select Sector Index (300%). Their fees differ too: 1.29% for UBOT and 1.08% for CURE.

Which has better risk-adjusted returns?

CURE currently has the higher Sharpe Ratio (0.60 vs 0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.